GlyFN Rapid Point-of-Care Test for Assessing the Risk of Pre-eclampsiaKnow the risk. Learn more.
Results in 10 minutes
Easy sample collection
Simple finger prick sample
Results obtained in 10 minutes
98.5% Sensitivity and 92.8% Specificity1
Can be used as early as 13 weeks gestation
Enquire about Lumella® here
What is Lumella®?
Lumella® is a rapid point-of-care (POC) test which predicts the risk of pre-eclampsia. The test determines the concentration of the Glycosylated Fibronectin (GlyFN) biomarker, which has increased levels during pre-eclampsia. Studies have shown it is a robust biomarker for the prediction of pre-eclampsia as both an immunoassay, POC test and compared to other biomarkers available. As a simple POC test which only requires a finger prick sample, the Lumella® test can be performed on the ward or in a doctor’s surgery, without needing the blood sample to go the lab.
How do you use the Lumella® GlyFN test?
The Lumella® test can be used in the first, second or third trimesters between 13 – 37 weeks.
The test only requires a 5µl finger prick sample, so there is no venepuncture unlike other pre-eclampsia diagnostic tests.
The blood sample is micropipetted into a buffer solution. The cartridge is inserted into a reader, and the blood-buffer solution is micropipeetted onto the cartridge.
After 10 minutes the results of the GlyFN levels will automatically be printed.
- Store Test Kits in a cool, dry place between 2–30 °C, (35–86 °F).
- Test cartridges stored in a refrigerator at 2–8 °C (35–46 °F) must be brought to room temperature before opening and using.
- Do not freeze.